Covid gen banner

COVID-19 related diagnostics in the clinical lab

At a time when demand for intensive care units (ICU) is at an unprecedented high, the rapid diagnosis of disease has never been more important.

According to EU recommendations, timely and accurate COVID-19 laboratory testing is an essential part of the management of COVID-19. Testing helps slow down the pandemic, support decisions on infection control strategies and patient management at healthcare facilities, and detect asymptomatic cases that could spread the virus further if not isolated.i

COVID-19 is often accompanied by a secondary bacterial or viral infection in the immuno-compromised individual. Rapid diagnosis is critical to determine the correct course of treatment. A study on patients in Wuhan, China, found that of the patients who died from infection around half had a secondary bacterial infection leading to sepsis and death.ii

It is therefore crucial that effective treatments are found to tackle COVID-19, and that broader testing for rapid diagnosis and early treatment of secondary bacterial infections becomes a key part of the response

Early testing, diagnosis and intervention significantly increases the likelihood of an individual’s recovery – where a gain in minutes or hours can mean the difference between life and death. Reducing the need for prolonged and often invasive ICU treatment, the chance of recovery is greater and vital resources are available more quickly for the next patient.

With clinical laboratories across the globe under intense pressure to deliver increased demand for test results, Bruker’s molecular and diagnostic systems offer a rapid response. A swift and accurate diagnosis establishes the correct course of action straightaway, which, ultimately means fewer lives will be lost.


i European Centre for Disease Prevention and Control (ECDC), 1 April 2020.

ii Zhou F et al. Lancet 2020; 395: 1054–62. DOI:

For IVD-CE products: please contact your local representative for availability in your country. Not for sale in the USA.